Kraig Biocraft Labs Stock Performance
| KBLB Stock | USD 0.09 0.01 12.50% |
On a scale of 0 to 100, Kraig Biocraft holds a performance score of 2. The company secures a Beta (Market Risk) of -0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Kraig Biocraft are expected to decrease at a much lower rate. During the bear market, Kraig Biocraft is likely to outperform the market. Please check Kraig Biocraft's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether Kraig Biocraft's current price movements will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Kraig Biocraft Labs are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, Kraig Biocraft sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 816.9 K | |
| Total Cashflows From Investing Activities | -547.4 K | |
| Free Cash Flow | -1.9 M |
Kraig |
Kraig Biocraft Relative Risk vs. Return Landscape
If you would invest 9.00 in Kraig Biocraft Labs on December 2, 2024 and sell it today you would earn a total of 0.00 from holding Kraig Biocraft Labs or generate 0.0% return on investment over 90 days. Kraig Biocraft Labs is currently generating 0.2073% in daily expected returns and assumes 6.5112% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of otc stocks are less volatile than Kraig, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Kraig Biocraft Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kraig Biocraft's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Kraig Biocraft Labs, and traders can use it to determine the average amount a Kraig Biocraft's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0318
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KBLB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.51 actual daily | 58 58% of assets are less volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Kraig Biocraft is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kraig Biocraft by adding it to a well-diversified portfolio.
Kraig Biocraft Fundamentals Growth
Kraig OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Kraig Biocraft, and Kraig Biocraft fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kraig OTC Stock performance.
| Return On Asset | -0.32 | |||
| Current Valuation | 34.14 M | |||
| Shares Outstanding | 1.02 B | |||
| Price To Earning | (9.37) X | |||
| Price To Sales | 1,199 X | |||
| EBITDA | (2.64 M) | |||
| Cash And Equivalents | 4.82 M | |||
| Total Debt | 95.24 K | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 3.02 M | |||
| Retained Earnings | (22.47 M) | |||
| Current Asset | 356 K | |||
| Current Liabilities | 2.68 M | |||
About Kraig Biocraft Performance
By analyzing Kraig Biocraft's fundamental ratios, stakeholders can gain valuable insights into Kraig Biocraft's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kraig Biocraft has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kraig Biocraft has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 38 people.Things to note about Kraig Biocraft Labs performance evaluation
Checking the ongoing alerts about Kraig Biocraft for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Kraig Biocraft Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kraig Biocraft Labs had very high historical volatility over the last 90 days | |
| Kraig Biocraft Labs has some characteristics of a very speculative penny stock | |
| Kraig Biocraft Labs currently holds 95.24 K in liabilities. Kraig Biocraft Labs has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Kraig Biocraft until it has trouble settling it off, either with new capital or with free cash flow. So, Kraig Biocraft's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kraig Biocraft Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kraig to invest in growth at high rates of return. When we think about Kraig Biocraft's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (8.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kraig Biocraft Labs currently holds about 4.82 M in cash with (1.8 M) of positive cash flow from operations. | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Kraig Biocraft's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kraig Biocraft's stock is overvalued or undervalued compared to its peers.
- Examining Kraig Biocraft's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kraig Biocraft's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kraig Biocraft's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Kraig Biocraft's otc stock. These opinions can provide insight into Kraig Biocraft's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kraig OTC Stock analysis
When running Kraig Biocraft's price analysis, check to measure Kraig Biocraft's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kraig Biocraft is operating at the current time. Most of Kraig Biocraft's value examination focuses on studying past and present price action to predict the probability of Kraig Biocraft's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kraig Biocraft's price. Additionally, you may evaluate how the addition of Kraig Biocraft to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |